Showing results (111-120 of 292) with videos related to
Sort By:
Pageof 30
Obesity Pillars|April 21, 2026
Structured higher protein meal replacement plans for weight loss and metabolic health: A qualitative narrative evidence review of Medifast interventionsAlexandra J Miller, Christopher D Coleman, Jessica R Kiel, et al.Obesity Pillars|June 8, 2026
Erratum: Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity SocietyDariush Mozaffarian, Monica Agarwal, Monica Aggarwal, et al.Obesity Pillars|November 22, 2023
Whole-body bone mineral density and markers of bone homeostasis in adults with normal-weight obesityBryant H Keirns, Christina M Sciarrillo, Austin R Medlin, et al.Obesity Pillars|July 12, 2026
Understanding reasons for initiation and experience with tirzepatide among individuals with obesity or overweight: Results from the PERCEPTIONS surveyTheresa Hunter Gibble, Harriet Makin, Claire Gerber, et al.Obesity Pillars|July 11, 2026
Epidemiology of osteoarthritis overall and by body mass index category in the United States: A retrospective analysis of the National Health and Nutrition Examination SurveyTammy Forrester, Juliana Meyers, Abby Hitchens, et al.Obesity Pillars|July 13, 2026
Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE studyDemsina Babazadeh, Stephanie Therrien, Angela K Fitch, et al.Obesity Pillars|June 22, 2026
Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropionMichael Kyle, David M Savastano, Terrilyn A Sharpe, et al.Obesity Pillars|June 30, 2026
Using Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) to improve access to obesity pharmacotherapy: A practical guide for clinicians caring for youth with obesity across United States Medicaid programs: Abbreviated title: Using EPSDT to Improve Access to Obesity PharmacotherapyJaime M Moore, Valerie M O'Hara, Cassie Totman, et al.Obesity Pillars|June 8, 2026
Virtual shared medical appointments for obesity and GLP-1 medications: A scalable method for optimizing care deliveryJacob Mirsky, Olayemi Olubowale, Ryan M KaneObesity Pillars|July 28, 2026
Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS SurveyTheresa Hunter Gibble, Tamara Al-Zubeidi, Claire Gerber, et al.Pageof 30